Company Data

Context Therapeutics Inc.

Advanced Market Data

Ticker

CNTX

Current Price

$1.4 2.19%

Market Cap

$22.4M

Price Target

Refer to Report

Volume

80.6K

52wk Range

$0.95 - $10.87

Advanced Market Data

Overview

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Other Considerations

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

$0.1231

$0.14(-11.69%)

2.5M

983.2K

$0.121 - $14.5215

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Imugene Ltd.

IUGNF (OTO)

$0.13

828.1M

83.0K

$0.0837 - $0.404

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PsyBio Therapeutics

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PsyBio Therapeutics

PsyBio Therapeutics

PSYBF (OTO)

$0.04

$0.04(-8.78%)

4.5M

22.1K

$0.029 - $0.2925

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Axcella Therapeutics

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Axcella Therapeutics

Axcella Therapeutics

AXLA (Nasdaq)

$0.8698

$0.93(-6.47%)

31.7M

191.6K

$0.7006 - $3.03

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Psybio Therapeutics Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Psybio Therapeutics Corp.

Psybio Therapeutics Corp.

PSYB:CA (CDX)

$0.06

$0.06(9.09%)

6.7M

38.0K

$0.04 - $0.34

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data